Meglutol
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C6H10O5 |
Molar mass | 162.141 g/mol |
3D model (JSmol) | |
|
WikiDoc Resources for Meglutol |
Articles |
---|
Most recent articles on Meglutol |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Meglutol at Clinical Trials.gov Clinical Trials on Meglutol at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Meglutol
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating Meglutol Risk calculators and risk factors for Meglutol
|
Healthcare Provider Resources |
Causes & Risk Factors for Meglutol |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Meglutol (INN, also known as 3-hydroxy-3-methylglutaric acid, β-hydroxy-β-methylglutaric acid, and dicrotalic acid) is a hypolipidemic agent.
References
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drug
- Cardiovascular Drugs
- Hypolipidemic agents